Atlas FDA

Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve

FDA premarket approval P140031/S151 · decided 2023-01-20

Approval details

PMA number
P140031
Supplement
S151
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve
Generic name
Aortic valve, prosthesis, percutaneously delivered
Applicant
Edwards Lifesciences, LLC
Date received
2023-01-05
Decision date
2023-01-20
Days to decision
15 days
Decision code
APPR
Product code
NPT
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
Approval for a manufacturing site located at 35 Changi North Crescent, Changi South East, SG 499641 (Edwards Lifesciences Singapore Pte Ltd.) for RESILIA tissue processing.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Respiration Rate algorithm (K251326)Edwards Lifesciences, LLC2026-06-11
HemoSphere Nano Monitor (HSNANO1) (K253186)Edwards Lifesciences, LLC2026-02-24
Edwards MC3 Tricuspid annuloplasty ring (4900) (K251982)Edwards Lifesciences, LLC2025-09-23
Carpentier-Edwards Physio Annuloplasty Ring (4450) (K251688)Edwards Lifesciences, LLC2025-09-17
Hypertension Prediction Index (HePI) Algorithm (K242518)Edwards Lifesciences, LLC2025-05-15
FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors (K242909)Edwards Lifesciences, LLC2025-03-21
Fogarty Thru-Lumen Embolectomy Catheter (K240078)Edwards Lifesciences, LLC2024-08-28
Acumen Assisted Fluid Management (AFM) Software Feature (K233984)Edwards Lifesciences, LLC2024-08-02